New program aims to stop second strokes in young adults

NCT ID NCT06820411

Ongoing Prevention Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests a personalized lifestyle program for young adults (18-65) who have had a stroke or high-risk mini-stroke. The program includes intensive counseling on diet, exercise, and smoking, plus a wearable device to track health. Researchers want to see if this approach is practical and can help reduce the chance of another stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Young Stroke Clinic Lifestyle Intervention (personalized risk management, lifestyle counseling, wearable device monitoring)
What this could lead to: If successful, this program could provide a practical way to help young stroke survivors lower their risk of having another stroke and improve their overall health.
What could go wrong: This is a small pilot study with only 36 participants, so results may not apply to everyone. It tests feasibility, not effectiveness, and the program requires significant commitment from participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE AT A YOUNG AGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE AT A YOUNG AGE SECONDARY PREVENTION

Contacts and locations

Locations

IRCCS National Neurological Institute "C. Mondino" Foundation, Pavia, Pavia 27100

Pavia, PV, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.